Ingredia’s Pep2Dia addresses prediabetes with whey protein hydrolysate
14 Sep 2023 | Ingredia
Ingredia’s patented ingredient from cow’s milk is positioned to help consumers control their glycemic health. The clinically tested whey protein hydrolysate is seeing increased interest on the market as type 2 diabetes cases are on the rise, reports the company. Laurie-Anne Giacomini, product manager at Ingredia, explains how the ingredient’s “inhibiting effect” can help consumers achieve more stable blood sugar levels.
